Now available in public domain, big data (information) has the potential to transform healthcare, like it has revolutionized other industries. It has now become critical to use big data in any FDA-regulated industry – for reducing cost, improving patient outcomes and saving lives. Healthcare stakeholders that take the lead in investing in big-data initiatives will not only gain competitive advantage but also save significantly on resources.
In this webinar, industry veteran David Lim will discuss practical, actionable and sustainable approaches to help FDA-regulated industry benefit from big data applications. Lim will show you how to most effectively identify and apply big data insights to your FDA-regulated business (drugs and medical devices including IVDs, dietary supplements, cosmetics, etc.).
Lim will share his best practices – including dos, don’ts and tips that help you save time, energy and money by strategically applying big data insights to your business practices.
This presentation is a must for you if you’re a regulatory professional working in any FDA-regulated healthcare industry – including drugs, biologics, biosimilars, medical devices and IVDs, combination products, etc.
After attending this webinar, you will learn how to develop and implement best practices to systematically use and benefit from big data.
This session will bring you up to speed with:
Who Should Attend
Ask a question at the Q&A session following the live event and get advice unique to your situation, directly from our expert speaker.
Dr. David Lim, Ph.D., RAC, ASQ-CQA. Dr. Lim is President and Principal of Regulatory Consulting Firm, Regulatory Doctor (www.RegulatoryDoctor.us). As a leading industry speaker, Dr. Lim frequently presents various topics in areas of FDA regulatory, clinical, quality and regulatory compliance matters in various forums and meetings.